Targeting of Immune Response After Pneumococcal Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pneumococcal Pneumonia
Interventions
BIOLOGICAL

Pneumococcal polysaccharide vaccine

Pneumococcal polysaccharide vaccine 0.5 ml i.m.

BIOLOGICAL

pneumococcal conjugate vaccine

pneumococcal conjugate vaccine 0.5 ml i.m.

Trial Locations (4)

20520

University of Turku, Turku

00014

University of Helsinki, Haartman institute, Dept. of Bacteriology and Immunology, Helsinki

00029

Division of Infectious Diseases, HUCH, Helsinki

Division of Microbiology, HUSLAB, Helsinki University Central Hospital, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT01402245 - Targeting of Immune Response After Pneumococcal Vaccination | Biotech Hunter | Biotech Hunter